These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32151183)

  • 1. The Cre8 amphilimus-eluting stent for the treatment of coronary artery disease: safety and efficacy profile.
    Pivato CA; Leone PP; Petriello G; Sanz-Sanchez J; Chiarito M; Stefanini GG
    Expert Rev Med Devices; 2020 Apr; 17(4):267-275. PubMed ID: 32151183
    [No Abstract]   [Full Text] [Related]  

  • 2. Five-year clinical outcome of multicenter randomized trial comparing amphilimus - with paclitaxel-eluting stents in de novo native coronary artery lesions.
    Carrié D; Berland J; Verheye S; Hauptmann KE; Vrolix M; Musto C; Berti S; Dibié A; Maupas E; Antoniucci D; Schofer J
    Int J Cardiol; 2020 Feb; 301():50-55. PubMed ID: 31759686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Polymer-Free Drug-Eluting Stents.
    Chiarito M; Sardella G; Colombo A; Briguori C; Testa L; Bedogni F; Fabbiocchi F; Paggi A; Palloshi A; Tamburino C; Margonato A; Pivato CA; Baber U; Calcagno S; Giordano A; Godino C; Stefanini GG
    Circ Cardiovasc Interv; 2019 Feb; 12(2):e007311. PubMed ID: 30767663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes of real-world patients treated with an amphilimus polymer-free stent versus new generation everolimus-eluting stents.
    Panoulas VF; Latib A; Naim C; Sato K; Ielasi A; Tespili M; Godino C; Testa L; Bedogni F; Colombo A
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1168-76. PubMed ID: 26269415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter randomized trial comparing amphilimus- with paclitaxel-eluting stents in de novo native coronary artery lesions.
    Carrié D; Berland J; Verheye S; Hauptmann KE; Vrolix M; Violini R; Dibie A; Berti S; Maupas E; Antoniucci D; Schofer J
    J Am Coll Cardiol; 2012 Apr; 59(15):1371-6. PubMed ID: 22284328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients: Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTre rEgistry).
    Colombo A; Godino C; Donahue M; Testa L; Chiarito M; Pavon AG; Colantonio R; Cappelletti A; Monello A; Magni V; Milazzo D; Parisi R; Nicolino A; Moshiri S; Fattori R; Aprigliano G; Palloshi A; Caramanno G; Montorfano M; Bedogni F; Margonato A; Briguori C
    Int J Cardiol; 2016 Jul; 214():113-20. PubMed ID: 27060269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of the amphilimus-eluting polymer-free stent for chronic total occlusion treatment: a multicentre experience.
    Maeremans J; Cottens D; Azzalini L; Pereira B; Godino C; Carlino M; Colombo A; Frambach P; Bellini B; Candilio L; Briguori C; Pierri A; Lamers S; Roux L; Duponselle J; Vrolix M; Dens J
    J Cardiovasc Med (Hagerstown); 2018 Oct; 19(10):564-570. PubMed ID: 30124545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances with polymer-free amphilimus-eluting stents.
    CARRIé D
    Minerva Cardioangiol; 2016 Jun; 64(3):339-53. PubMed ID: 26934663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cre8™ coronary stent: preclinical in vivo assessment of a new generation polymer-free DES with Amphilimus™ formulation.
    Moretti C; Lolli V; Perona G; Vignolini MC; Cabiale K; Falzone M; Galloni M
    EuroIntervention; 2012 Jan; 7(9):1087-94. PubMed ID: 22130128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymer-free amphilimus-eluting stents in patients with diabetes mellitus.
    Romaguera R; Gómez-Lara J; Jacobi F; Gomez-Hospital JA; Cequier A
    Minerva Cardioangiol; 2014 Oct; 62(5):421-6. PubMed ID: 25295493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes with reservoir-based polymer-free amphilimus-eluting stents in real-world patients according to diabetes mellitus and complexity: The INVESTIG8 registry.
    Sardella G; Stella P; Chiarito M; Leone AM; Balian V; Prosperi F; Sorropago G; Mancone M; Calcagno S; Briguori C; Stefanini GG
    Catheter Cardiovasc Interv; 2018 Apr; 91(5):884-891. PubMed ID: 28707375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymer-free sirolimus- and probucol-eluting versus new generation zotarolimus-eluting stents in coronary artery disease: the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting versus Zotarolimus-eluting Stents (ISAR-TEST 5) trial.
    Massberg S; Byrne RA; Kastrati A; Schulz S; Pache J; Hausleiter J; Ibrahim T; Fusaro M; Ott I; Schömig A; Laugwitz KL; Mehilli J;
    Circulation; 2011 Aug; 124(5):624-32. PubMed ID: 21768546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and study design of the RESERVOIR trial: a randomized trial comparing reservoir-based polymer-free amphilimus-eluting stents versus everolimus-eluting stents with durable polymer in patients with diabetes mellitus.
    Romaguera R; Brugaletta S; Gomez-Lara J; Pinar E; Jiménez-Quevedo P; Gracida M; Roura G; Ferreiro JL; Teruel L; Gómez-Hospital JA; Montanya E; Alfonso F; Valgimigli M; Sabate M; Cequier A
    Catheter Cardiovasc Interv; 2015 Mar; 85(4):E116-22. PubMed ID: 25380051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nine-month angiographic and two-year clinical follow-up of polymer-free sirolimus-eluting stent versus durable-polymer sirolimus-eluting stent for coronary artery disease: the Nano randomized trial.
    Zhang Y; Chen F; Muramatsu T; Xu B; Li Z; Ge J; He Q; Yang Z; Li S; Wang L; Wang H; He B; Li K; Qi G; Li T; Zeng H; Peng J; Jiang T; Zeng Q; Zhu J; Fu G; Bourantas CV; Serruys PW; Huo Y
    Chin Med J (Engl); 2014; 127(11):2153-8. PubMed ID: 24890170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the MiStent sustained sirolimus eluting biodegradable polymer coated stent for the treatment of coronary artery disease: does uniform sustained abluminal drug release result in earlier strut coverage and better safety profile?
    Tijssen RYG; Kraak RP; Lu H; Mifek JG; Carlyle WC; Donohoe DJ; De Winter RJ; Koch KT; Wykrzykowska JJ
    Expert Rev Med Devices; 2017 May; 14(5):325-334. PubMed ID: 28402204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized All-Comers Evaluation of a Permanent Polymer Zotarolimus-Eluting Stent Versus a Polymer-Free Amphilimus-Eluting Stent.
    Rozemeijer R; Stein M; Voskuil M; van den Bor R; Frambach P; Pereira B; Koudstaal S; Leenders GE; Timmers L; Rittersma SZ; Kraaijeveld AO; Agostoni P; Roes KC; Doevendans PA; Stella PR;
    Circulation; 2019 Jan; 139(1):67-77. PubMed ID: 30586704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymer Free Amphilimus Drug Eluting Stent for Infrapopliteal Arterial Disease in Patients with Critical Limb Ischemia: A New Device in the Armamentarium.
    Tigkiropoulos K; Abatzis-Papadopoulos M; Sidiropoulou K; Stavridis K; Karamanos D; Lazaridis I; Saratzis N
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676663
    [No Abstract]   [Full Text] [Related]  

  • 18. Technical overview on the MiStent coronary stent.
    McCLAIN JB; Carlyle WC; Donohoe DJ; Ormiston JA
    Minerva Cardioangiol; 2016 Oct; 64(5):560-71. PubMed ID: 27152624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
    Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymer-free amphilimus-eluting stent versus biodegradable polymer biolimus-eluting stent in patients with and without diabetes mellitus.
    Godino C; Pivato CA; Chiarito M; Donahue M; Testa L; Colantonio R; Cappelletti A; Milazzo D; Parisi R; Nicolino A; Moshiri S; Aprigliano G; Palloshi A; Zavalloni Parenti D; Rutigliano D; Locuratolo N; Melillo F; Scotti A; Arrigoni L; Montorfano M; Fattori R; Presbitero P; Sardella G; Bedogni F; Margonato A; Briguori C; Colombo A;
    Int J Cardiol; 2017 Oct; 245():69-76. PubMed ID: 28874301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.